Cluster of Differentiation 19 (CD19)/B Cell Maturation Antigen (BCMA) Chimeric Antigen Receptor T-Cell (CAR-T) Therapy for Refractory Autoimmune Diseases

​ Conditions: Autoimmune Diseases

Interventions: Drug: CD19/BCMA-targeted CAR-T lentiviral vector drug

Sponsors: Shenzhen Genocury Biotech Co., Ltd.

Not yet recruiting Conditions: Autoimmune Diseases
Interventions: Drug: CD19/BCMA-targeted CAR-T lentiviral vector drug
Sponsors: Shenzhen Genocury Biotech Co., Ltd.
Not yet recruiting